EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis

Darren R Veach, Daniela Burnes Vargas, Baharul Islam, Sang Gyu Lee, Leah Gajecki, Brett A Vaughn, Guangbin Yang, Teja Muralidhar Kalidindi, Naga Vara Kishore Pillarsetty iD, Niloufar Salehi, Ambika P Jaswal, Sayani Saha und 8 weitere

Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3265-3275

DOI: 10.1021/acs.molpharmaceut.5c01766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.05.2026. Verfasst von Darren R Veach und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring, Radioimmunotherapy, Radiopharmaceuticals. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesHeterocyclic Compounds, 1-RingRadioimmunotherapyRadiopharmaceuticalsAnimalsHumansMicePositron-Emission TomographyCell Line, TumorFemaleAntibodies, BispecificTissue DistributionMice, Nude

Stichwörter der Autor:innen

GPA33bispecific antibodygallium-68pretargetedradioimmunodiagnosis

Substanzen

Gallium RadioisotopesHeterocyclic Compounds, 1-Ring1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidRadiopharmaceuticalsAntibodies, BispecificGallium-68

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Department of Radiology, Weill Cornell Medicine, New York, New York 10021, United States.
  • Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York 10021, United States.
  • Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

ORCID-Profile: Naga Vara Kishore Pillarsetty, Nai-Kong V Cheung, Steven M Larson

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Veach, D. R., Burnes Vargas, D., Islam, B., Lee, S. G., Gajecki, L., Vaughn, B. A., Yang, G., Kalidindi, T. M., Pillarsetty, N. V. K., Salehi, N., Jaswal, A. P., Saha, S., Le Roux, A. B., Xu, H., Guo, H. F., Ouerfelli, O., Cheung, N. V., Krebs, S., Larson, S. M., & Cheal, S. M. (2026). Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. Molecular Pharmaceutics, 23(6), 3265-3275. https://doi.org/10.1021/acs.molpharmaceut.5c01766

Vancouver

Veach DR, Burnes Vargas D, Islam B, Lee SG, Gajecki L, Vaughn BA, et al. Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. Molecular Pharmaceutics. 2026;23(6):3265-3275. doi:10.1021/acs.molpharmaceut.5c01766

BibTeX
@article{Veach2026,
  author = {Veach, Darren R and Burnes Vargas, Daniela and Islam, Baharul and Lee, Sang Gyu and Gajecki, Leah and Vaughn, Brett A and Yang, Guangbin and Kalidindi, Teja Muralidhar and Pillarsetty, Naga Vara Kishore and Salehi, Niloufar and Jaswal, Ambika P and Saha, Sayani and Le Roux, Alexandre B and Xu, Hong and Guo, Hong-Fen and Ouerfelli, Ouathek and Cheung, Nai-Kong V and Krebs, Simone and Larson, Steven M and Cheal, Sarah M},
  title = {Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {6},
  pages = {3265--3275},
  doi = {10.1021/acs.molpharmaceut.5c01766}
}
Kostenlos starten →